U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta - Physician's Weekly

U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta  Physician's Weekly

Aug 29, 2019 | Reuters | 0 |. (Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...